Skip to main content

Table 3 Study characteristics of 12 included prospective studies

From: Congruence between patients’ preferred and perceived participation in medical decision-making: a review of the literature

 

Study population

Treatment decision

Study design

Quality of studies**

Number (gender)

Age (mean) (range)

Patient population

 

Data collection

 

Preference prospectively measured

Brown et al., 2012 USA [15]

683 women

55.3

Breast cancer

General

RCT questionnaire before and after consultation

3

 

-

Butow et al., 2004 Australia [29]

75 men

58

Cancer

General

RCT Questionnaires before and after consultation

3

89 women

-

Clayton et al., 2011 USA [32]

62 men

43.2

Patients from general practice

General

self-reported data

2

107 women

18-89

Davison and Degner, 2002 Canada [31]

749 women

58.3

Breast cancer

General

Prospective, blocked, two-arm randomized controlled trial

1

-

Degner et al., 1997 Canada [12]

1012 women

-

Breast cancer

Operation

Cross-sectional, consecutive sampling, nurse administrated questionnaire

3

 

58.3

Ernst et al., 2010 Germany [17]

59 men

57

Hemato-oncological illnesses

General

Postal review interview

1

45 women

21-84

Gattellari et al., 2001 Australia [27]

133 men

56.7

Cancer

General

RCT prospective, cross-sectional consecutive sampling self-administered questionnaire

4

100 women

22-82

Janz et al., 2004 USA [26]

101 women

54.9

Breast cancer

Operation

Telephone interviews

4

34-81

Kasper et al., 2008 Germany [30]

79 men

43.1

MS

Medication

RCT; telephone and post, standardized questionnaires

4

218 women

-

Leighl et al., 2011 Canada [24]

62 men

62.5

Colorectal cancer

Medication

RCT

2

38 women

-

Ramfelt et al., 2000 Sweden [25]

41 men

70

Colorectal cancer

Operation

Questionnaires

3

45 women

34-84

Wunderlich et al., 2010 USA [28]

134 men

58

Colorectal cancer

Screening

Pre- and post-visit survey

1

229 women

-

  1. Table sorted alphabetically.
  2. Note **:Methodological quality of studies assessed with MMAT(23), ranging from 0 (lowest) to 4 (highest).